GWS
VIVO

Glassman Wealth Services’s Meridian Bioscience Inc VIVO Stock Holding History

Glassman Wealth Services’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-17
Closed – – 1461
2019
Q1 		$0 Hold
17
– – ﹤0.01% 1247
2018
Q4 		$0 Hold
17
– – ﹤0.01% 1034
2018
Q3 		$0 Sell
17
-3
-15% -$47 ﹤0.01% 995
2018
Q2 		$0 Hold
20
– – ﹤0.01% 992
2018
Q1 		$0 Hold
20
– – ﹤0.01% 965
2017
Q4 		$0 Buy
+20
New +$293 ﹤0.01% 828

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Glassman Wealth Services's VIVO Position: Q2 2019 in Review

Glassman Wealth Services sold out of Meridian Bioscience Inc (VIVO) in Q2 2019, closing a stake of 17 shares.

Glassman Wealth Services first reported a position in VIVO in Q4 2017 and held it in 6 quarters. The position peaked at $0 in Q1 2019. 173 funds tracked by Wall St. Rank hold VIVO as of Q2 2019.

  • Glassman Wealth Services reported no remaining Meridian Bioscience Inc position as of Q2 2019 after selling out during the quarter.
  • Glassman Wealth Services sold 17 Meridian Bioscience Inc shares in Q2 2019.
  • Glassman Wealth Services first reported a position in Meridian Bioscience Inc in Q4 2017 and held it in 6 quarters.
  • Glassman Wealth Services's Meridian Bioscience Inc position peaked at $0 in Q1 2019.
  • 173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2019.

Based on Glassman Wealth Services's 13F filing for Q2 2019, filed 8 Aug 2019.